Product Code: PM2300
The global carrier screening market size is expected to reach USD 3.64 billion by 2030, according to a new study by Polaris Market Research. The report "Carrier Screening Market Share, Size, Trends, Industry Analysis Report, By Type (Expanded Carrier Screening, Targeted Disease Carrier Screening); By Medical Condition; By Technology; By End-User; By Regions; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The well-established healthcare infrastructure and the rise in innovative product introductions are driving the expansion of the industry. Many countries concentrate their efforts on developing enhanced medical infrastructure that includes enhanced treatment techniques.
Furthermore, developed-country nations have modern healthcare infrastructure integrated with various transmission methods, pushing the rise and need for these techniques throughout such countries. Many people wish to discover if their genetic or inherited disorders might be transmitted to their offerings. As a result, these factors are expected to open up promising growth opportunities for companies in the overall industry during the forecasted period.
Additionally, the increasing prevalence of fetal chromosomal abnormalities boosts industry growth. According to the WHO, congenital abnormalities are major causes of fetal and infant mortality, chronic illness, and disabilities. Every year, an estimated 295 000 newborns nationwide die within 28 days of birth due to congenital abnormalities. Thus, the rising prevalence of fetal abnormalities, increasing product launches, and established healthcare infrastructure propel the industry growth during the forecast period.
Based on the type, the expanded segment accounted for the leading share in the industry in 2021. Customized panel testing and predesigned panel testing are the extended segment components. Due to advancements in DNA sequencing, polymerase chain reaction, metabolomics, and other technologies, the expanded sector accounted for most of the global market share in 2021.
Market players such as Abbott Laboratories, 23Andme Inc., Autogenomics Inc., Danaher Corporation, Fulgent Genetics Inc., Eurofins Scientific, Illumina Inc., Luminex Corporation, Invitae Corporation, MedGenome, Natera Inc., Myriad Genetics, Opko Health, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., Roche AG, Sequenom Inc., and True Health. are some key players operating in the global market.
Polaris Market Research has segmented the carrier screening market report based on type, medical condition, technology, end-user, and region:
Carrier Screening, Type Outlook (Revenue - USD Billion, 2018 - 2030)
Expanded
Customized Panel Testing
Predesigned Panel Testing
Targeted Disease
Carrier Screening, Medical Condition Outlook (Revenue - USD Billion, 2018 - 2030)
Pulmonary Conditions
Hematological Conditions
Neurological Conditions
Other Conditions
Carrier Screening, Technology Outlook (Revenue - USD Billion, 2018 - 2030)
DNA Sequencing
Polymerase Chain Reaction
Microarrays
Other Technologies
Carrier Screening, End-User Outlook (Revenue - USD Billion, 2018 - 2030)
Hospitals
Reference Laboratories
Physician Offices & Clinics
Other End Users
Carrier Screening, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
France
Germany
UK
Italy
Netherlands
Spain
Austria
Asia Pacific
China
India
Japan
Malaysia
South Korea
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Carrier Screening Market Insights
- 4.1. Carrier Screening - Industry Snapshot
- 4.2. Carrier Screening Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing emphasis on early disease detection & prevention
- 4.2.1.2. Increasing awareness of carrier screening
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of service
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Carrier Screening Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Carrier Screening Market, by Medical Condition
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 5.3. Pulmonary Conditions
- 5.3.1. Global Carrier Screening Market, by Pulmonary Conditions, by Region, 2018 - 2030 (USD Billion)
- 5.4. Hematological Conditions
- 5.4.1. Global Carrier Screening Market, by Hematological Conditions, by Region, 2018 - 2030 (USD Billion)
- 5.5. Neurological Conditions
- 5.5.1. Global Carrier Screening Market, by Neurological Conditions, by Region, 2018 - 2030 (USD Billion)
- 5.6. Other Conditions
- 5.6.1. Global Carrier Screening Market, by Other Conditions, by Region, 2018 - 2030 (USD Billion)
6. Global Carrier Screening Market, by Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 6.3. Expanded
- 6.3.1. Global Carrier Screening Market, by Expanded, by Region, 2018 - 2030 (USD Billion)
- 6.3.2. Customized Panel Testing
- 6.3.2.1. Global Carrier Screening Market, by Customized Panel Testing, by Region, 2018 - 2030 (USD Billion)
- 6.3.3. Predesigned Panel Testing
- 6.3.3.1. Global Carrier Screening Market, by Predesigned Panel Testing, by Region, 2018 - 2030 (USD Billion)
- 6.4. Targeted Disease
- 6.4.1. Global Carrier Screening Market, by Targeted Disease, by Region, 2018 - 2030 (USD Billion)
7. Global Carrier Screening Market, by Technology
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 7.3. DNA Sequencing
- 7.3.1. Global Carrier Screening Market, by DNA Sequencing, by Region, 2018 - 2030 (USD Billion)
- 7.4. Polymerase Chain Reaction
- 7.4.1. Global Carrier Screening Market, by Polymerase Chain Reaction, by Region, 2018 - 2030 (USD Billion)
- 7.5. Microarrays
- 7.5.1. Global Carrier Screening Market, by Microarrays, by Region, 2018 - 2030 (USD Billion)
- 7.6. Other Technologies
- 7.6.1. Global Carrier Screening Market, by Other Technologies, by Region, 2018 - 2030 (USD Billion)
8. Global Carrier Screening Market, by End-User
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Global Carrier Screening Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
- 8.4. Reference Laboratories
- 8.4.1. Global Carrier Screening Market, by Reference Laboratories, by Region, 2018 - 2030 (USD Billion)
- 8.5. Physician Offices & Clinics
- 8.5.1. Global Carrier Screening Market, by Physician Offices & Clinics, by Region, 2018 - 2030 (USD Billion)
- 8.6. Other End Users
- 8.6.1. Global Carrier Screening Market, by Other End Users, by Region, 2018 - 2030 (USD Billion)
9. Global Carrier Screening Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Carrier Screening Market Assessment, By Geography, 2018 - 2030 (USD Billion)
- 9.3. Carrier Screening Market - North America
- 9.3.1. North America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.3.2. North America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.3. North America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.4. North America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.3.5. Carrier Screening Market - U.S.
- 9.3.5.1. U.S.: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.3.5.2. U.S.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.5.3. U.S.: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.5.4. U.S.: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.3.6. Carrier Screening Market - Canada
- 9.3.6.1. Canada: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.3.6.2. Canada: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.3.6.3. Canada: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.3.6.4. Canada: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4. Carrier Screening Market - Europe
- 9.4.1. Europe: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.2. Europe: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.3. Europe: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.4. Europe: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.5. Carrier Screening Market - UK
- 9.4.5.1. UK: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.5.2. UK: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.5.3. UK: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.5.4. UK: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.6. Carrier Screening Market - France
- 9.4.6.1. France: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.6.2. France: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.6.3. France: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.6.4. France: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.7. Carrier Screening Market - Germany
- 9.4.7.1. Germany: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.7.2. Germany: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.7.3. Germany: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.7.4. Germany: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.8. Carrier Screening Market - Italy
- 9.4.8.1. Italy: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.8.2. Italy: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.8.3. Italy: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.8.4. Italy: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.9. Carrier Screening Market - Spain
- 9.4.9.1. Spain: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.9.2. Spain: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.9.3. Spain: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.9.4. Spain: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.10. Carrier Screening Market - Netherlands
- 9.4.10.1. Netherlands: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.10.2. Netherlands: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.10.3. Netherlands: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.10.4. Netherlands: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.4.11. Carrier Screening Market - Austria
- 9.4.11.1. Austria: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.4.11.2. Austria.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.4.11.3. Austria: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.4.11.4. Austria: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5. Carrier Screening Market - Asia Pacific
- 9.5.1. Asia Pacific: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.2. Asia Pacific: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.3. Asia Pacific: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.4. Asia Pacific: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.5. Carrier Screening Market - China
- 9.5.5.1. China: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.5.2. China.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.5.3. China: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.5.4. China: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.6. Carrier Screening Market - India
- 9.5.6.1. India: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.6.2. India.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.6.3. India: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.6.4. India: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.7. Carrier Screening Market - Japan
- 9.5.7.1. Japan: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.7.2. Japan.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.7.3. Japan: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.7.4. Japan: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.8. Carrier Screening Market - Malaysia
- 9.5.8.1. Malaysia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.8.2. Malaysia.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.8.3. Malaysia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.8.4. Malaysia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.9. Carrier Screening Market - Indonesia
- 9.5.9.1. Indonesia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.9.2. Indonesia.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.9.3. Indonesia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.9.4. Indonesia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.5.10. Carrier Screening Market - South Korea
- 9.5.10.1. South Korea: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.5.10.2. South Korea.: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.5.10.3. South Korea: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.5.10.4. South Korea: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6. Carrier Screening Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.2. Middle East & Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.3. Middle East & Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.4. Middle East & Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.5. Carrier Screening Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.5.2. Saudi Arabia: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.5.3. Saudi Arabia: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.5.4. Saudi Arabia: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.6. Carrier Screening Market - South Africa
- 9.6.6.1. South Africa: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.6.2. South Africa: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.6.3. South Africa: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.6.4. South Africa: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.7. Carrier Screening Market - Israel
- 9.6.7.1. Israel: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.7.2. Israel: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.7.3. Israel: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.7.4. Israel: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.6.8. Carrier Screening Market - UAE
- 9.6.8.1. UAE: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.6.8.2. UAE: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.6.8.3. UAE: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.6.8.4. UAE: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7. Carrier Screening Market - Latin America
- 9.7.1. Latin America: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.7.2. Latin America: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.3. Latin America: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.4. Latin America: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.5. Carrier Screening Market - Mexico
- 9.7.5.1. Mexico: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.7.5.2. Mexico: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.5.3. Mexico: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.5.4. Mexico: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.6. Carrier Screening Market - Brazil
- 9.7.6.1. Brazil: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.7.6.2. Brazil: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.6.3. Brazil: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.6.4. Brazil: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
- 9.7.7. Carrier Screening Market - Argentina
- 9.7.7.1. Argentina: Carrier Screening Market, by Medical Condition, 2018 - 2030 (USD Billion)
- 9.7.7.2. Argentina: Carrier Screening Market, by End-User, 2018 - 2030 (USD Billion)
- 9.7.7.3. Argentina: Carrier Screening Market, by Type, 2018 - 2030 (USD Billion)
- 9.7.7.4. Argentina: Carrier Screening Market, by Technology, 2018 - 2030 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. 23Andme Inc.
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Abbott Laboratories
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Autogenomics Inc.
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Danaher Corporation
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Eurofins Scientific
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Fulgent Genetics Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Illumina Inc.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Invitae Corporation
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Luminex Corporation
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. MedGenome
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Myriad Genetics
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Natera Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Opko Health
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Quest Diagnostics Incorporated
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Roche AG
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Sequenom Inc.
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
- 11.17. Thermo Fisher Scientific Inc.
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
- 11.18. True Health
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development